博雅生物 公告，公司参与设立 华润医药 产业投资基金二期，认缴出资6,000万元人民币，占基金份额6%。基金规模为10亿元人民币，主要旨在储备优质战略项目资源。目前已签署合伙协议，条款未发生重大变化。本次交易符合公司战略规划，不会对公司财务状况和经营成果产生重大影响，但存在一定的投资与运营风险。
Source Link博雅生物 公告，公司参与设立 华润医药 产业投资基金二期，认缴出资6,000万元人民币，占基金份额6%。基金规模为10亿元人民币，主要旨在储备优质战略项目资源。目前已签署合伙协议，条款未发生重大变化。本次交易符合公司战略规划，不会对公司财务状况和经营成果产生重大影响，但存在一定的投资与运营风险。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.